title: Testicular expression and distribution of the rat bcl2 modifying factor in response to reduced intratesticular testosterone.
abstract: The Bcl2 modifying factor (Bmf) is a pro-apoptotic member of the Bcl2 family of apoptosis-related proteins that has been shown to initiate apoptosis in response to the loss of attachment of cells from their basal lamina (anoikis). Experimental reduction in intratesticular testosterone concentration brings about the death of spermatids as a consequence of their sloughing from Sertoli cells. Given the role of Bmf in anoikis in other systems, we hypothesized that Bmf would be expressed in germ cells and that its expression and normal distribution might be altered under conditions that induce widespread germ cell loss. To test these hypotheses, we demonstrated that Bmf indeed is expressed in the testis and cloned the full-length rat Bmf cDNA. Immunohistochemistry revealed that Bmf is present in the subacrosomal space of postmeiotic spermatids from step 4 to 16 of spermiogenesis. To test the hypothesis that Bmf expression and distribution are altered by conditions that elicit anoikis, intratesticular testosterone was reduced by implanting Silastic capsules containing testosterone and estradiol into adult rats for 8 weeks. As hypothesized, this resulted in a significant change in Bmf distribution relative to untreated animals. In particular, Bmf exhibited a loss of its normal subacrosomal distribution, becoming redistributed throughout the cytoplasm and nucleus, and appeared in cells in which it is not normally expressed (e.g., pachytene spermatocytes). Additionally, Bmf mRNA expression increased in response to lowered testosterone. These results suggest that Bmf may well be involved in germ cell apoptosis and/or anoikis in response to decreased intratesticular testosterone concentration.
authors.affiliation: Division of Reproductive Biology, Department of Biochemistry and Molecular Biology, The Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland 21205, USA. mshow@jhsph.edu
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Show
authors.forename: Janet S
authors.initials: JS
authors.lastname: Folmer
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Anway
authors.forename: Barry R
authors.initials: BR
authors.lastname: Zirkin
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D002214:Capsules; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D003001:Cloning, Molecular; D018076:DNA, Complementary; D004338:Drug Combinations; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D008297:Male; D009994:Osmolar Concentration; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012670:Seminiferous Epithelium / Q000378:metabolism; D013737:Testis / Q000378:metabolism*; D013739:Testosterone / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D014018:Tissue Distribution
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C486656:Bmf protein, rat; D002214:Capsules; D002352:Carrier Proteins; D018076:DNA, Complementary; D004338:Drug Combinations; D004343:Drug Implants; D012333:RNA, Messenger; D013739:Testosterone; D004958:Estradiol